Literature DB >> 27325861

Can Stereotactic Body Radiotherapy Really Be Considered the Preferred Treatment in Large Hepatocellular Carcinoma?

Berardino De Bari1, Mahmut Ozsahin2, Pierre Bize2, Tarek Boussaha2, Gaël Deplanque2, Dorothea Wagner2, Jean Bourhis2, Alban Denys2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27325861      PMCID: PMC5019756          DOI: 10.1200/JCO.2016.66.7196

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

1.  Stereotactic body radiation therapy: the report of AAPM Task Group 101.

Authors:  Stanley H Benedict; Kamil M Yenice; David Followill; James M Galvin; William Hinson; Brian Kavanagh; Paul Keall; Michael Lovelock; Sanford Meeks; Lech Papiez; Thomas Purdie; Ramaswamy Sadagopan; Michael C Schell; Bill Salter; David J Schlesinger; Almon S Shiu; Timothy Solberg; Danny Y Song; Volker Stieber; Robert Timmerman; Wolfgang A Tomé; Dirk Verellen; Lu Wang; Fang-Fang Yin
Journal:  Med Phys       Date:  2010-08       Impact factor: 4.071

Review 2.  [Radiosensitivity of hepatocellular carcinoma].

Authors:  C Hennequin; L Quero; S Rivera
Journal:  Cancer Radiother       Date:  2011-01-14       Impact factor: 1.018

3.  Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  C Verslype; O Rosmorduc; P Rougier
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

Review 4.  Treatment algorithms for managing hepatocellular carcinoma.

Authors:  Vivek A Saraswat; Gaurav Pandey; Sachin Shetty
Journal:  J Clin Exp Hepatol       Date:  2014-06-06

5.  Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.

Authors:  Daniel R Wahl; Matthew H Stenmark; Yebin Tao; Erqi L Pollom; Elaine M Caoili; Theodore S Lawrence; Matthew J Schipper; Mary Feng
Journal:  J Clin Oncol       Date:  2015-11-30       Impact factor: 44.544

6.  Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study.

Authors:  Tito Livraghi; Luigi Solbiati; M Franca Meloni; G Scott Gazelle; Elkan F Halpern; S Nahum Goldberg
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

Review 7.  Role of stereotactic body radiation therapy for hepatocellular carcinoma.

Authors:  Naoko Sanuki; Atsuya Takeda; Etsuo Kunieda
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

8.  Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.

Authors:  Shuichiro Shiina; Ryosuke Tateishi; Toru Arano; Koji Uchino; Kenichiro Enooku; Hayato Nakagawa; Yoshinari Asaoka; Takahisa Sato; Ryota Masuzaki; Yuji Kondo; Tadashi Goto; Haruhiko Yoshida; Masao Omata; Kazuhiko Koike
Journal:  Am J Gastroenterol       Date:  2011-12-13       Impact factor: 10.864

9.  Stereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma.

Authors:  Sang Min Yoon; Young-Suk Lim; Mee Jin Park; So Yeon Kim; Byungchul Cho; Ju Hyun Shim; Kang Mo Kim; Han Chu Lee; Young-Hwa Chung; Yung Sang Lee; Sung Gyu Lee; Yu Sun Lee; Jin-Hong Park; Jong Hoon Kim
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

  9 in total
  1 in total

1.  Reply to Yang et al and De Bari et al.

Authors:  Daniel R Wahl; Yebin Tao; Matthew Schipper; Theodore S Lawrence; Mary Feng
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.